Advertisement
Advertisement

APTO

APTO logo

Aptose Biosciences Inc

0.1815
USD
-0.0061
-3.25%
Dec 18, 13:19 UTC -5
Open

Aptose Biosciences Inc Profile

About

Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.

Info & Links

CEO

William G. Rice

Headquarters

251 CONSUMERS ROAD, SUITE 1105
TORONTO, A6 M2J 4R3, CANADA

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.aptose.com

Auditor

KPMG LLP

Share holders

30

Employees

36

Aptose Biosciences Inc Statistics

Valuation Measures

Market Capitalization2

3.29M

Enterprise Value

5.32M

Enterprise Value/EBITDA(ttm)

-0.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-5683.22%

Return on Invested Capital(ttm)

-7094.01%

Return on Assets(ttm)

-300.44%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-35.78M

Net Income Available to Common(ttm)

-35.80M

Diluted EPS(ttm)

-2.97

Share Statistics

Beta (5Y Monthly)

1.06

52-Week Change

-92.56%

S&P 500 52-Week Change

26.62%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

57.81M

% Held by Insiders

3.94%

% Held by Institutions

26.62%

Balance Sheet

Total Cash(mrq)

7.96M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

10.00M

Total Debt/Equity(mrq)

-109.48%

Current Ratio(mrq)

1.05%

Quick Ratio(mrq)

1.05%

Book Value Per Share(mrq)

-0.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.50

Free Cash Flow(ytd)

-27.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement